| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 4,255 | 3,719 | +14.4% |
| EBITDA | 555 | 649 | −14.5% |
| EBITDA margin | 13.0% | 17.5% | −4.4 pts |
| Profit before tax | 127 | 318 | −60.1% |
| Net profit | 60.0 | 316 | −81.0% |
| EPS | −₹0.67 | ₹9.89 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 15,350 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1,092 | 1,092 | 1,353 | 1,040 | 1,778 | ||
| 969 | 969 | 907 | 873 | 921 | ||
| 8,001 | 8,001 | 7,072 | 5,563 | 6,296 | ||
| 23,228 | — | — | — | — | ||
| 15,120 | 14,584 | 14,887 | 15,421 | 16,789 | ||
| — | −2.0% | −3.5% | −8.1% | — | ||
| 1,711 | 1,805 | 1,953 | 2,847 | 3,822 | ||
| 11.3% | 12.4% | 13.1% | 18.5% | 22.8% | ||
| 454 | 604 | 830 | 1,867 | 2,930 | ||
| −1,971 | −1,715 | 387 | 435 | 2,434 | ||
| −13.0% | −11.8% | 2.6% | 2.8% | 14.5% | ||
| −₹84.90 | −₹74.35 | ₹9.22 | ₹10.51 | ₹90.86 | ||
| — | −906.8% | −12.3% | −88.4% | — | ||
| — | 1,269 | 1,761 | 3,016 | 2,971 | ||
| — | −1,205 | −2,005 | −1,834 | −1,578 | ||
| 64.0 | 64.0 | −244 | 1,182 | 1,393 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 15,349.7 | |
| - Cash, Equiv & ST Investments | 1,778.0 | 1,040.0 | 1,353.0 | 1,092.0 | 1,092.0 | |
| + Minority Interest | 921.0 | 873.0 | 907.0 | 969.0 | 969.0 | |
| + Total Debt | 6,296.0 | 5,563.0 | 7,072.0 | 8,001.0 | 8,001.0 | |
| Enterprise Value | — | — | — | — | 23,227.7 | |
| Revenue | 16,789.0 | 15,421.0 | 14,887.0 | 14,584.0 | 15,120.0 | |
| Growth %, YoY | — | -8.1 | -3.5 | -2.0 | — | |
| EBITDA | 3,822.0 | 2,847.0 | 1,953.0 | 1,805.0 | 1,711.0 | |
| Margin % | 22.76 | 18.46 | 13.12 | 12.38 | 11.32 | |
| EBIT | 2,930.0 | 1,867.0 | 830.0 | 604.0 | 454.0 | |
| Net Income | 2,434.0 | 435.0 | 387.0 | -1,715.0 | -1,971.0 | |
| Margin % | 14.50 | 2.82 | 2.60 | -11.76 | -13.04 | |
| EPS, Adj (current shares) | 90.86 | 10.51 | 9.22 | -74.35 | -84.90 | |
| Growth %, YoY | — | -88.4 | -12.3 | -906.8 | — | |
| Cash from Operations | 2,971.0 | 3,016.0 | 1,761.0 | 1,269.0 | — | |
| Capital Expenditures | -1,578.0 | -1,834.0 | -2,005.0 | -1,205.0 | — | |
| Free Cash Flow | 1,393.0 | 1,182.0 | -244.0 | 64.0 | 64.0 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Tata Chemicals (NSE: TATACHEM) had a market capitalisation of ₹15,388 crore at the 29 October 2026 close (₹603.45 a share) and a price-to-book ratio of 0.73. In FY26 its consolidated net loss was ₹1,896 crore on revenue of ₹14,584 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹17 crore. Its debt-to-equity ratio was 0.36 on 31 March 2026. Promoters held 37.98% of the shares on 30 September 2026.
Tata Chemicals' PE ratio is not meaningful at the 29 October 2026 close: its consolidated net profit attributable to shareholders over the last four quarters (Q2 FY26 to Q1 FY27) was a loss of ₹2,165 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹15,388 crore at ₹603.45 a share.
Tata Chemicals' price-to-book (PB) ratio is 0.73 at the 29 October 2026 close: a market capitalisation of ₹15,388 crore divided by shareholders' equity (book value) of ₹21,206 crore on 31 March 2026. That is a book value of ₹831.61 per share against a share price of ₹603.45.
Tata Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹21,206 crore on 31 March 2026, down 1.8% from ₹21,594 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹15,388 crore at the 29 October 2026 close.
Tata Chemicals' market capitalisation was ₹15,388 crore at the 29 October 2026 close: 25.5 crore shares at ₹603.45 each.
Tata Chemicals' basic earnings per share (EPS) were −₹74.42 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to −₹77.68.
In 2026, Tata Chemicals has declared one dividend: ₹11 with record date 10 June 2026.
No. Tata Chemicals had borrowings of ₹8,001 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.36. Its cash and current investments were ₹1,153 crore, so its net debt was ₹6,848 crore.
Tata Chemicals' dividend yield is 1.82% at the 29 October 2026 close: dividends of ₹11 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹603.45. They were ₹11 on 10 June 2026.
Promoters held 37.98% of Tata Chemicals on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Tata Chemicals' debt-to-equity ratio was 0.36 on 31 March 2026: borrowings of ₹8,001 crore against total equity of ₹22,175 crore. A year earlier, on 31 March 2025, it was 0.31.
In FY26, Tata Chemicals generated ₹1,269 crore of cash from operations and spent ₹1,205 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹64 crore. In FY25 it was −₹244 crore.
In FY26 (April 2025–March 2026), Tata Chemicals' consolidated net loss was ₹1,896 crore, against a profit of ₹235 crore in FY25, on revenue from operations of ₹14,584 crore (down 2.0%).
In FY26, Tata Chemicals' return on equity (ROE) was −8.9% and its return on capital employed (ROCE) was 1.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 1.1% and ROCE 2.7%.
Tata Chemicals' book value per share was ₹831.61 on 31 March 2026: shareholders' equity of ₹21,206 crore divided by the 25.5 crore shares in issue, down 1.8% from ₹846.82 a year earlier. The share price at the 29 October 2026 close was ₹603.45.
In FY26, Tata Chemicals earned net profit attributable to shareholders of ₹1,896 crore on revenue of ₹14,584 crore, against ₹472 crore on ₹3,064 crore for GHCL. Tata Chemicals' operating margin was 4.1% (GHCL 18.9%) and its return on equity −8.9% (GHCL 13.4%). At the 29 October 2026 close, Tata Chemicals' market capitalisation was ₹15,388 crore against ₹3,573 crore for GHCL.
On 30 September 2026, Tata Chemicals' shares were held by promoters 37.98%, foreign portfolio investors (FII/FPI) 11.70%, domestic institutions (DII) 19.65% (including mutual funds at 8.19%) and retail and other non-institutional investors 30.64%. Over the year, FII holding was down 2.04 percentage points from 13.74% and DII holding was down 2.53 percentage points from 22.18%.
Tata Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 27 July 2026: consolidated net loss ₹17 crore, against a profit of ₹252 crore in Q1 FY26; revenue from operations ₹4,255 crore, up 14.4% year on year.
On FY26 consolidated figures, against GHCL, Aarti Industries and J.G.Chemicals: Tata Chemicals' operating margin of 4.1% is the lowest of the four (GHCL 18.9%, Aarti Industries 8.4%, J.G.Chemicals 7.9%; peer average 11.7%); its return on equity of −8.9% is the lowest of the four (GHCL 13.4%, Aarti Industries 7.3%, J.G.Chemicals 13.3%; peer average 11.3%).
Tata Chemicals will announce its Q2 FY27 results (July–September 2026) on Saturday, 7 November 2026, the date of the board meeting it has notified to the exchanges.
From Tata Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.